| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.00072 | 1 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.00075 | 1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.00061 | 1 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.00062 | 1 |